CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...